Clinical Trial Update: An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating long-term efficacy and safety of escitalopram in major depressive disorder with associated anxiety symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED